Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Capital Expenditures (2017 - 2025)

Inspire Medical Systems (INSP) has disclosed Capital Expenditures for 9 consecutive years, with $10.7 million as the latest value for Q4 2025.

  • Quarterly Capital Expenditures fell 70.12% to $10.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $38.5 million through Dec 2025, down 1.59% year-over-year, with the annual reading at $38.5 million for FY2025, 1.59% down from the prior year.
  • Capital Expenditures hit $10.7 million in Q4 2025 for Inspire Medical Systems, up from $10.4 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $35.7 million in Q4 2024 to a low of -$20.6 million in Q3 2024.
  • Historically, Capital Expenditures has averaged $5.2 million across 5 years, with a median of $3.1 million in 2022.
  • Biggest five-year swings in Capital Expenditures: crashed 344.74% in 2022 and later skyrocketed 1252.84% in 2024.
  • Year by year, Capital Expenditures stood at -$383000.0 in 2021, then surged by 291.91% to $735000.0 in 2022, then soared by 992.93% to $8.0 million in 2023, then skyrocketed by 344.01% to $35.7 million in 2024, then plummeted by 70.12% to $10.7 million in 2025.
  • Business Quant data shows Capital Expenditures for INSP at $10.7 million in Q4 2025, $10.4 million in Q3 2025, and $9.0 million in Q2 2025.